0001183740-11-000233.txt : 20110324
0001183740-11-000233.hdr.sgml : 20110324
20110324090845
ACCESSION NUMBER: 0001183740-11-000233
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20110324
DATE AS OF CHANGE: 20110324
EFFECTIVENESS DATE: 20110324
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOVASC INC
CENTRAL INDEX KEY: 0001399708
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-157247
FILM NUMBER: 11707926
BUSINESS ADDRESS:
STREET 1: 2135 13700 Mayfield place
CITY: RICHMOND
STATE: A1
ZIP: 00000
BUSINESS PHONE: 604-270-4344
MAIL ADDRESS:
STREET 1: 2135 13700 Mayfield place
CITY: RICHMOND
STATE: A1
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: Medical Ventures Corp
DATE OF NAME CHANGE: 20070516
D
1
primary_doc.xml
X0704
D
LIVE
0001399708
NEOVASC INC
2135-13700 MAYFIELD PLACE
RICHMOND
A1
BRITISH COLUMBIA, CANADA
00000
604-270-4344
BRITISH COLUMBIA, CANADA
Medical Ventures Corp
Corporation
true
ALEXEI
MARKO
2135-13700 MAYFIELD PLACE
RICHMOND
A1
BRITISH COLUMBIA, CANADA
V6V 2E4
Executive Officer
Director
PAUL
GEYER
2135-13700 MAYFIELD PLACE
RICHMOND
A1
BRITISH COLUMBIA, CANADA
V6V 2E4
Executive Officer
Director
DOUG
JANZEN
2135-13700 MAYFIELD PLACE
RICHMOND
A1
BRITISH COLUMBIA, CANADA
V6V 2E4
Director
STEVEN
RUBIN
2135-13700 MAYFIELD PLACE
RICHMOND
A1
BRITISH COLUMBIA, CANADA
V6V 2E4
Director
JANE
HSIAO
2135-13700 MAYFIELD PLACE
RICHMOND
A1
BRITISH COLUMBIA, CANADA
V6V 2E4
Director
WILLIAM
O'NEILL
2135-13700 MAYFIELD PLACE
RICHMOND
A1
BRITISH COLUMBIA, CANADA
V6V 2E4
Director
BOAZ
LIFSCHITZ
2135-13700 MAYFIELD PLACE
RICHMOND
A1
BRITISH COLUMBIA, CANADA
V6V 2E4
Director
CHRIS
CLARK
2135-13700 MAYFIELD PLACE
RICHMOND
A1
BRITISH COLUMBIA, CANADA
V6V 2E4
Executive Officer
BRIAN
MCPHERSON
2135-13700 MAYFIELD PLACE
RICHMOND
A1
BRITISH COLUMBIA, CANADA
V6V 2E4
Executive Officer
Biotechnology
Decline to Disclose
- 06
false
2011-03-16
false
true
false
0
26215
26215
0
13(a) represents the price of the options exercised (65,000 options @ C$0.40), converted to US$ based on the exchange rate on the date of exercise, March 16, 2011, of US$1.00=C$0.9918.
false
1
0
0
0
false
NEOVASC INC
/s/ Chris Clark
Chris Clark
Chief Financial Officer
2011-03-23